Pacatang, Junrey C.
HRN: 26-24/02 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/16/2024
CEFTAZIDIME 1GM (VIAL)
11/16/2024
11/23/2024
IV
1g
Q8
Open Fracture
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Bone & Joint Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes